This webinar is part of a series of informative webinars created to complement the iREACH 2023 podcast series, REACHing for Vaccine Equity. February’s topic focuses on heart disease and vaccines and features a presentation from REACH recipients from YMCA Health Savannah.
Coming soon! REACHing for Vaccine Equity is a limited-series podcast. Each episode provides examples of vaccine equity initiatives and tips for community leaders.
REACHing for Vaccine Equity is a limited series podcast produced by the iREACH team at the Association of Immunization Managers (AIM). This series of informative episodes discusses how individuals living with chronic health conditions, including heart disease, diabetes, clinical depression, and more, can continue to thrive with the preventative power of getting vaccinated and adopting healthy behaviors.
In this webinar, REACH recipients discuss lessons learned from working with faith-based communities to increase flu and COVID-19 vaccination rates.
Hot Topics with the SMEs is an informal meeting every Tuesday at 2 pm ET where Dr. Yabo, Dr. Fiscus, and Lisa, present hot topics in the immunization world.
AIM's reminder/recall (RR) program aims to increase immunization rates by assisting members in designing and coordinating reminder/recall postcard mailings.
On December 9, 2022, the CDC (following authorization by the FDA), CDC expanded the use of updated (bivalent) COVID-19 booster vaccines for children ages 6 months through 5 years. Learn more here.
Voices for Vaccines is a family-led pro-vaccine organization providing credible, fact-based resources for families and communities. Find easy-to-understand resources for building vaccine confidence, learning about vaccine safety, and understanding community immunity.
Vaccines include ingredients to help them do their work. Each ingredient used to make a vaccine has a specific purpose. Certain ingredients, just like preservatives in foods, help keep vaccines safe from contamination and toxins that could make us sick.
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.